Apollo Hospitals Enterprise Limited · NSE:APOLLOHOSP
Apollo Hospitals Enterprise — Q1 FY2023 Earnings Presentation
24 slides from Apollo Hospitals Enterprise's earnings presentation, Aug 12, 2022
Slide 1: Regulation 30 disclosure cover letter
APOLLO HOSPITALS ENTERPRISE LIMITED Albilo IHOSPITALS CIN: L85110TN1979PLC008035 TOUCHING LIVES 12th August 2022 The Secretary, The Secretary, Bombay Stock Exchange Ltd (BSE) National Stock Exchange, Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor Dalal Street, Plot No.C/1, 'G' Block Mumbai -
Slide 2: Earnings Update Q1 FY 2023
Bia, EARNINGS UPDATE Q1 FY 2023
Slide 3: Disclaimer
DISCLAIMER • No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all events not current after the
Slide 4: Key Highlights
Key Highlights HIGHLIGHTS CONSOLIDATED FINANCIAL OPERATIONAL PARAMETERS PERFORMANCE HOSPITALS APOLLO HEALTH CO LTD APOLLO HEALTH & LIFESTYLE LTD ANNEXURE 3
Slide 5: Highlights
HIGHLIGHTS i
Slide 6: Highlights
HIGHLIGHTS ▪ Q1 FY23 Consolidated Revenues of ` 37,956 mio (growth of 1% yoy); grew by 7% yoy excluding vaccination revenue in Q1FY22. ▪ Q1 FY23 Consolidated EBITDA of ` 4,907 mio. Financial ▪ Consolidated PAT of ` 3,171 mio in Q1 FY23. PAT before adjusting for Deferred tax reversal on Migration to
Slide 7: Highlights
HIGHLIGHTS ▪ 71 hospitals with total bed capacity of 9,911 beds as on June 30, 2022. ▪ 44 owned hospitals including JVs/ Subsidiaries and Associates with 8,538 beds. ▪ 11 Day care/ short surgical stay centres with 244 beds and 11 Cradles with 278 beds. Capacity ▪ 5 Managed hospitals with 851 beds. ▪
Slide 8: Consolidated Financial Performance
CONSOLIDATED FINANCIAL PERFORMANCE
Slide 9: Consolidated Financial Performance
CONSOLIDATED FINANCIAL PERFORMANCE TOTAL (` mio) Q1 FY 22 Q1 FY 23 yoy (%) Total Revenues 37,602 37,956 0.9% EBITDA (Post Ind AS 116) 5,199 4,907 -5.6% margin (%) 13.8% 12.9% -90 bps EBIT 3,793 3,430 -9.6% margin (%) 10.1% 9.0% -105 bps Profit After Tax (Reported) 4,893 3,171 -35.2% Deferred Tax Rev
Slide 10: Consolidated Financial Performance: Mature & New Breakup Q1 FY23
CONSOLIDATED FINANCIAL PERFORMANCE MATURE & NEW BREAKUP – Q1 FY23 (` mio) Healthcare Healthcare Serv *Health Co Key Highlights Healthcare Serv & Serv Group Group (New incl AHLL Consol Group (Total) Pharmacy (Mature) Proton) Distribution HCS revenue grew by 4.3% in Q1FY23 Hospitals 29 15 44 Revenue g
Slide 11: Operational Parameters - Hospitals
OPERATIONAL PARAMETERS - HOSPITALS
Slide 12: Operational Parameters - Hospitals
OPERATIONAL PARAMETERS - HOSPITALS (` mio) Tamilnadu Region AP, Telengana Region (Hyderabad Karnataka Region Significant Subs/JVs/associates Total (6) (2) (3) Others (4) (Chennai & others) (1) & others) (Bangalore & others) (5) Particulars Q1 FY 22 Q1 FY 23 yoy (%) Q1 FY 22 Q1 FY 23 yoy (%) Q1 FY 22
Slide 13: Apollo Health Co Ltd
APOLLO HEALTH CO LTD This is the first quarter of full operations post Demerger of Supply chain and Digital health platform into AHL.
Slide 14: Apollo Health Co
APOLLO HEALTH CO Reorganization through Slump Sale (effected on 16th March 2022) AHEL (Listed) • Apollo 24/7 represents Apollo Group’s transformational journey to creating “India’s Largest Omnichannel Digital Healthcare Platform” that: Pharmacy ▪ combines the strengths of Apollo Group’s offline heal
Slide 15: Pharmacy Distribution
PHARMACY DISTRIBUTION (` mio) Q1 FY 22 Q1 FY 23 yoy (%) Revenue 15,120 14,792 -2.2% EBITDA (Post Ind AS 116)** 1,153 1,119 -3.0% margin (%) 7.6% 7.6% -6 bps *Health Co from 16th March 2022 **EBITDA Post Ind AS 116 - excluding 24/7 operating costs No of Pharmacies : 4,761 • Added 249 stores and Close
Slide 16: Apollo 24x7 - India's Largest Omni-Channel Healthcare Platform
APOLLO 24X7 – INDIA’S LARGEST OMNI-CHANNEL HEALTHCARE PLATFORM LEVERAGING PHYSICAL NETWORK Cumulative upto 30th June 2022 ~17Mn Registrations Distinctive digital 5 ecosystem … 4 Condition 6 management Digital services Online diagnostic Health predictor ~6.5 Lakh+ Daily Active Users 3 booking 7 Well-
Slide 17: Apollo 24x7 - Q1 FY23 Updates
APOLLO 24X7 – Q1 FY23 UPDATES • Q1 delivered GMV : ~215 cr (higher by 21% vs Q4 and 34% excluding Jan 22 Omicron surge in business) • On track to deliver ~1500 cr. of GMV in FY22-23 against earlier guidance of ~1000 cr. • Expect to incur 20% additional expenditure in Digital business (~550 cr. of an
Slide 18: Apollo Health & Lifestyle Ltd
APOLLO HEALTH & LIFESTYLE LTD
Slide 19: AHLL - Q1 FY23
AHLL – Q1 FY23 (` mio) Q1 FY23 Clinics Diagnostics Sugar Dental Dialysis Cradles (IP) IVF Spectra (IP) Key Highlights Network 268 1,419 52 97 95 8 15 11 Footfalls/Day* 3,400 10,218 478 200 1,504 44 28 94 Core revenues of AHLL ( i.e., Gross ARPP (Rs.)* 1,276 733 3,229 5,749 1,574 100,288 38,726 102,4
Slide 20: Annexure
ANNEXURE i
Slide 21: Annexure 1: Standalone Financial Performance
ANNEXURE 1 :STANDALONE FINANCIAL PERFORMANCE TOTAL (` mio) Q1 FY 22 Q1 FY 23 yoy (%) Revenue 14,827 15,297 3.2% Operative Expenses 4,746 4,643 -2.2% Employee Expenses 2,991 2,651 -11.4% Administrative & Other Expenses 3,967 4,120 3.8% Total Expenses 11,704 11,414 -2.5% EBITDA (Post Ind AS 116) 3,123
Slide 22: Annexure 2: Ind AS 116 Impact on P&L and Balance Sheet
ANNEXURE 2 : IND AS - 116 IMPACT ON P&L AND BALANCE SHEET – Q1 FY23 (` mio) AHEL Standalone (post IND AS 116) AHEL Consolidated (post IND AS 116) Balance sheet Profit & Loss Balance sheet Profit & Loss Revenue - Right of use Revenue Right of use Asset as of 5,236 Asset as of 10,478 Other 203 Other e
Slide 23: Annexure 3: Basis of Consolidation
ANNEXURE 3 : BASIS OF CONSOLIDATION AHEL Standalone Location Description AHEL Ownership AHEL Chennai Main Chennai Hospital Subsidiaries Location Description Ownership Material Subs ACI - Chennai Chennai Hospital Apollo Health Co limited India Digital Omni-Channel Healthcare services 100.00% Tondiarp
Slide 24: Thank You
THANK YOU 23
Apollo Hospitals Enterprise — Q1 FY2023 Earnings Presentation on 6ix